ANCOBON Drug Patent Profile
✉ Email this page to a colleague
When do Ancobon patents expire, and what generic alternatives are available?
Ancobon is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in ANCOBON is flucytosine. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the flucytosine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ancobon
A generic version of ANCOBON was approved as flucytosine by SIGMAPHARM LABS LLC on June 28th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANCOBON?
- What are the global sales for ANCOBON?
- What is Average Wholesale Price for ANCOBON?
Summary for ANCOBON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 209 |
| Clinical Trials: | 2 |
| Patent Applications: | 3,881 |
| Drug Prices: | Drug price information for ANCOBON |
| What excipients (inactive ingredients) are in ANCOBON? | ANCOBON excipients list |
| DailyMed Link: | ANCOBON at DailyMed |
Recent Clinical Trials for ANCOBON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Valeant Pharmaceuticals International, Inc. | Phase 2 |
| Kenya Medical Research Institute | Phase 2 |
| University of Nairobi | Phase 2 |
Pharmacology for ANCOBON
| Drug Class | Nucleoside Analog Antifungal |
US Patents and Regulatory Information for ANCOBON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bausch | ANCOBON | flucytosine | CAPSULE;ORAL | 017001-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
